Sunshine Biopharma Income Statement (2010-2026) | SBFM

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	0.05M	0.05M	0.09M	0.12M	0.15M	0.13M	3.94M	4.89M	5.56M	5.96M	7.68M	7.54M	9.30M	8.44M	9.59M	8.90M	9.41M	9.42M	8.58M	8.09M
Cost of Revenue (Quarter)	0.02M	0.02M	0.06M	0.06M	0.09M	0.07M	2.25M	0.13M	3.61M	0.24M	0.23M	0.20M	0.26M	0.28M	-16.76M	0.40M	5.99M	0.24M	5.55M	0.25M
Gross Profit (Quarter)	0.03M	0.03M	0.02M	0.06M	0.08M	0.07M	1.49M	1.83M	1.95M	1.99M	2.57M	2.35M	2.36M	2.87M	3.09M	2.73M	3.42M	3.07M	3.03M	2.18M
Operating items
Research & Development (Quarter)	0.19M	0.22M	0.09M	0.36M	0.05M	0.36M	0.04M	0.43M	0.37M	0.24M	0.82M	0.22M	0.44M	0.13M	0.15M	0.22M	0.20M	0.12M	0.07M	0.03M
Selling, General & Administrative (Quarter)	0.42M	0.53M	0.30M	1.29M	0.77M	1.79M	24.85M	3.66M	2.97M	2.77M	3.76M	3.70M	3.62M	3.97M	5.13M	4.03M	5.48M	4.16M	4.82M	3.58M
Restructuring Costs (Quarter)										0.54M	0.72M	0.91M	0.71M	0.53M	0.91M	0.93M	0.81M	0.61M	1.52M	0.87M
Other Operating Expenses (Quarter)																		-0.01M	-7.00
Operating Expenses (Quarter)	0.61M	0.75M	0.39M	1.65M	0.82M	2.15M	24.90M	4.09M	3.34M	3.55M	5.29M	4.84M	4.77M	4.63M	6.19M	5.17M	6.48M	4.89M	6.41M	4.48M
Operating Income (Quarter)	-0.39M	-0.50M	-0.28M	-1.22M	-0.70M	-1.72M	-23.36M	-1.83M	-1.01M	-0.78M	-1.19M	-1.35M	-1.27M	-1.11M	-2.04M	-1.30M	-2.05M	-1.09M	-1.79M	-1.40M
EBIT (Quarter)	-0.39M	-0.50M	-0.28M	-1.22M	-0.70M	-1.72M	-23.36M	-1.83M	-1.01M	-0.78M	-1.19M	-1.35M	-1.27M	-1.11M	-2.04M	-1.30M	-2.05M	-1.09M	-1.79M	-1.40M
Non-operating items
Non Operating Interest Expenses (Quarter)				0.10M	0.09M	0.22M
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)	2.00
Other Non Operating Income (Quarter)	221.00	0.01M	19.00	-9.00	0.01M	25.00	-521.00	15.00	-261.00	40.00	-39.00	-0.01M	0.29M	0.02M	-0.34M	451.00	0.00M	253.00	-2.00	-18.00
Non Operating Income (Quarter)	-2.49M	-3.54M	0.95M	-0.01M	0.16M	0.26M	0.08M	0.17M	0.20M	0.17M	0.16M	0.09M	0.43M	0.12M	-0.25M	0.08M	0.07M	0.07M	0.06M	0.15M
Net income details
EBT (Quarter)	-2.88M	-4.04M	0.67M	-1.24M	-0.54M	-1.46M	-23.28M	-1.66M	-0.81M	-0.61M	-1.03M	-1.26M	-0.84M	-0.98M	-2.29M	-1.22M	-1.98M	-1.02M	-1.73M	-1.24M
Tax Provisions (Quarter)							0.23M	0.05M	0.09M	0.05M	0.18M	0.02M	0.15M	0.22M	0.26M	-0.04M	-0.21M	-0.14M	0.43M
Profit After Tax (Quarter)	-2.88M	-4.04M	0.83M	-1.24M	-0.55M	-1.50M	-23.33M	-1.69M	-0.41M	-1.11M	-0.76M	-1.83M	-1.33M	-0.35M	-1.63M	-1.15M	-1.77M	-1.49M	-2.65M	-1.52M
Income from Continuing Operations (Quarter)	-2.88M	-4.04M	0.67M	-1.24M	-0.54M	-1.46M	-23.51M	-1.70M	-0.90M	-0.66M	-1.21M	-1.28M	-0.98M	-1.20M	-2.54M	-1.18M	-1.77M	-0.88M	-2.16M	-1.24M
Consolidated Net Income (Quarter)	-2.88M	-4.04M	0.67M	-1.24M	-0.54M	-1.46M	-23.51M	-1.70M	-0.90M	-0.66M	-1.21M	-1.28M	-0.98M	-1.20M	-2.54M	-1.18M	-1.77M	-0.88M	-2.16M	-1.24M
Income towards Parent Company (Quarter)	-2.88M	-4.04M	0.67M	-1.24M	-0.54M	-1.46M	-23.51M	-1.70M	-0.90M	-0.66M	-1.21M	-1.28M	-0.98M	-1.20M	-2.54M	-1.18M	-1.77M	-0.88M	-2.16M	-1.24M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-2.88M	-4.04M	0.67M	-1.24M	-0.54M	-1.46M	-23.51M	-1.70M	-0.90M	-0.65M	-1.21M	-1.28M	-1.78M	-1.20M	-2.16M	-1.18M	-2.95M	0.30M	-2.14M	-1.24M
Additional items
EPS (Basic) (Quarter)	-0.02M	-0.03M	0.01M	-0.00M	-680.39	-0.00M	-0.03M	-0.00M	-711.44	-506.99	-995.87	-400.31	-357.55	-9.45	-30.75	-4.36	-6.56	0.65	-5.15	-2.54
EPS (Diluted) (Quarter)			0.01M	-0.00M	-680.39	-0.00M	-0.03M	-0.00M	-711.44	-506.99	-995.87	-400.31	-357.55	-9.45	-30.75	-4.36	-8.19	0.75	-5.45	-3.17
Shares Outstanding (Quarter)	120.00	127.00	131.00	264.00	792.00	944.00	759.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.13M	0.07M	0.27M	0.45M	0.46M	0.42M	0.49M
Shares Outstanding (Diluted) (Quarter)			131.00	264.00	792.00	944.00	759.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.13M	0.07M	0.27M	0.36M	0.39M	0.39M	0.39M
Shares Outstanding (Entity) (Quarter)	122.00	128.00	130.00	264.00	944.00	944.00	759.00	0.00M	0.00M	0.00M	0.00M
EBITDA (Quarter)	-0.39M	-0.50M	-0.28M	-1.22M	-0.70M	-1.72M	-23.36M	-1.83M	-1.01M	-0.78M	-1.19M	-1.35M	-1.27M	-1.11M	-2.04M	-1.30M	-2.05M	-1.09M	-1.79M	-1.40M
Interest Expenses (Quarter)	0.20M	0.05M	-0.25M	0.02M		2.00	0.03M	0.10M	0.11M	0.11M	0.03M	0.10M	0.10M	0.10M	0.01M	0.18M	0.19M	0.19M		0.18M
Tax Rate (Quarter)							-1.00%	-2.79%	-10.77%	-8.61%	-17.69%	-1.77%	-17.40%	-21.90%	-11.17%	3.29%	10.56%	13.46%	-24.89%

Research Tools

Developers

Sunshine Biopharma Income Statement (2010-2026) | SBFM

Research Tools

Developers

Sunshine Biopharma Income Statement (2010-2026) | SBFM

Create an account

Sign In

Reset Password